DK143991D0 - Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse - Google Patents

Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse

Info

Publication number
DK143991D0
DK143991D0 DK911439A DK143991A DK143991D0 DK 143991 D0 DK143991 D0 DK 143991D0 DK 911439 A DK911439 A DK 911439A DK 143991 A DK143991 A DK 143991A DK 143991 D0 DK143991 D0 DK 143991D0
Authority
DK
Denmark
Prior art keywords
acid addition
optically active
addition salts
compounds
pharmaceutical preparations
Prior art date
Application number
DK911439A
Other languages
English (en)
Other versions
DK143991A (da
Inventor
Tetsuhide Kamijo
Toshiaki Yamaguchi
Kazuhiko Ikegami
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of DK143991D0 publication Critical patent/DK143991D0/da
Publication of DK143991A publication Critical patent/DK143991A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK143991A 1990-08-08 1991-08-07 Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse DK143991A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2211208A JP2514855B2 (ja) 1990-08-08 1990-08-08 光学活性なアラニンアニリド誘導体の酸付加塩

Publications (2)

Publication Number Publication Date
DK143991D0 true DK143991D0 (da) 1991-08-07
DK143991A DK143991A (da) 1992-02-09

Family

ID=16602123

Family Applications (1)

Application Number Title Priority Date Filing Date
DK143991A DK143991A (da) 1990-08-08 1991-08-07 Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse

Country Status (13)

Country Link
EP (1) EP0472325B1 (da)
JP (1) JP2514855B2 (da)
KR (1) KR100192531B1 (da)
AT (1) ATE116296T1 (da)
AU (1) AU646276B2 (da)
CA (1) CA2048714A1 (da)
DE (1) DE69106276T2 (da)
DK (1) DK143991A (da)
ES (1) ES2066363T3 (da)
FI (1) FI101700B1 (da)
HK (1) HK1003787A1 (da)
HU (1) HU213210B (da)
NO (1) NO913004D0 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320273D0 (en) * 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
ZA942140B (en) * 1993-04-01 1994-10-03 Fisons Corp Salt of (S)-alpha-phenyl-2-pyridineethanamine useful in therapy
EA201190064A1 (ru) 2008-12-24 2012-02-28 Астразенека Аб Соединения этанамина и их применение для лечения депрессии

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE786875A (fr) * 1971-07-28 1973-01-29 Astra Pharma Prod Amide, methode pour sa preparation et ses compositions therapeutiques
US4696930A (en) * 1985-04-12 1987-09-29 Hoffmann-La Roche Inc. N-(heteroarylalkyl)acylanilide derivatives as antiarrhythmic agents
JPS6452797A (en) * 1987-01-06 1989-02-28 Takeda Chemical Industries Ltd Production of crystalline trh-tartrate

Also Published As

Publication number Publication date
HU912640D0 (en) 1992-01-28
DE69106276T2 (de) 1995-05-18
FI101700B (fi) 1998-08-14
JPH0495072A (ja) 1992-03-27
ES2066363T3 (es) 1995-03-01
KR920004334A (ko) 1992-03-27
EP0472325A2 (en) 1992-02-26
KR100192531B1 (ko) 1999-06-15
EP0472325B1 (en) 1994-12-28
EP0472325A3 (en) 1992-03-04
DE69106276D1 (de) 1995-02-09
JP2514855B2 (ja) 1996-07-10
ATE116296T1 (de) 1995-01-15
CA2048714A1 (en) 1992-02-09
AU646276B2 (en) 1994-02-17
DK143991A (da) 1992-02-09
FI913774A (fi) 1992-02-09
HUT58292A (en) 1992-02-28
FI913774A0 (fi) 1991-08-08
AU8145891A (en) 1992-02-13
NO913004D0 (no) 1991-08-01
HK1003787A1 (en) 1998-11-06
FI101700B1 (fi) 1998-08-14
HU213210B (en) 1997-03-28

Similar Documents

Publication Publication Date Title
DK535789A (da) Pyrimidindionderivater, fremgangsmaade til fremstilling heraf og antiarytmika omfattende samme
NO891698D0 (no) Pyridonkarboksylsyrederivater og fremgangsmaate for deres fremstilling.
DK359289D0 (da) 4-oxoquinolin-3-carboxylsyrederivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
DE68925223T2 (de) 3-Alkenyl-1-azabicyclo(3.2.0)hept-2-en-2-carbonsäure-Verbindungen
PH25859A (en) Composition for treatment of ischemic disorder
DK25386D0 (da) Pyrazolsulfonamidderivater, fremstilling deraf og herbicid indeholdende samme
NO883146D0 (no) Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling.
DE68922478T2 (de) Pyrazoloisoquinoline-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen.
FI891279A0 (fi) Antivirala tetrahydroimidazol /1,4/ benzodiazepin-2-oner.
DK183789A (da) 2-alkyl-3-benzoylbenzofuraner og laegemidler indeholdende disse
DK143991D0 (da) Syreadditionssalte af optisk aktive alaninanilidforbindelser og farmaceutiske praeparater indeholdende disse
NO158622C (no) Analogifremgangsmaate for fremstilling av benzosyrederivater med antimikrobiell aktivitet.
MA20369A1 (fr) Compositions a base de derives de la piperidine ,nouveaux derives de la piperidine et leurs procedes de preparation
DK141187A (da) 1-(3-(2-dialkylaminoethoxy)-2-thienyl)-3-phenyl-1-propanoner og syreadditionssalte deraf, fremgangsmaade af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse
DK165586A (da) Heterocycliske amidderivater, deres fremstilling og anvendelse som fungicider
HUT42271A (en) Fungicidal compositions and process for preparing azolyl-(aryloxymethyl)-dimethyl-pentinol derivatives applicable as active substance
DE69011174D1 (de) Catecholaminester.
TH10006A (th) พิริดาซิแนมีนที่ใช้ต่อต้านพิคอร์นาไวรัส

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment